Personal tools

Coexpression cluster:C3750: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|gostat_on_coexpression_clusters=GO:0005859!muscle myosin complex!0.0105086541858001!10398$GO:0016460!myosin II complex!0.0105086541858001!10398$GO:0006937!regulation of muscle contraction!0.0105086541858001!10398$GO:0008307!structural constituent of muscle!0.0105086541858001!10398$GO:0044449!contractile fiber part!0.0106754582204953!10398$GO:0043292!contractile fiber!0.0106754582204953!10398$GO:0016459!myosin complex!0.0152983128963348!10398$GO:0003012!muscle system process!0.0183484438164763!10398$GO:0006936!muscle contraction!0.0183484438164763!10398$GO:0051239!regulation of multicellular organismal process!0.0269312696017041!10398$GO:0015629!actin cytoskeleton!0.0269312696017041!10398
|gostat_on_coexpression_clusters=GO:0005859!muscle myosin complex!0.0105086541858001!10398$GO:0016460!myosin II complex!0.0105086541858001!10398$GO:0006937!regulation of muscle contraction!0.0105086541858001!10398$GO:0008307!structural constituent of muscle!0.0105086541858001!10398$GO:0044449!contractile fiber part!0.0106754582204953!10398$GO:0043292!contractile fiber!0.0106754582204953!10398$GO:0016459!myosin complex!0.0152983128963348!10398$GO:0003012!muscle system process!0.0183484438164763!10398$GO:0006936!muscle contraction!0.0183484438164763!10398$GO:0051239!regulation of multicellular organismal process!0.0269312696017041!10398$GO:0015629!actin cytoskeleton!0.0269312696017041!10398
|id=C3750
|id=C3750
|ontology_enrichment_celltype=CL:0000055!3.09e-23!180;CL:0000183!4.42e-14!59;CL:0000680!5.89e-14!57;CL:0000056!5.89e-14!57;CL:0000355!5.89e-14!57;CL:0000192!1.44e-13!42;CL:0000514!1.44e-13!42;CL:0000187!1.82e-13!54;CL:0000057!6.20e-13!75;CL:0000393!4.29e-12!60;CL:0000211!4.29e-12!60;CL:0000359!7.56e-11!32;CL:0000222!4.92e-10!119;CL:0000136!4.75e-07!15
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0005256!2.09e-18!143;UBERON:0000481!3.08e-17!347;UBERON:0000468!4.39e-16!659;UBERON:0000914!5.82e-16!83;UBERON:0002329!5.82e-16!83;UBERON:0003077!5.82e-16!83;UBERON:0003059!5.82e-16!83;UBERON:0007282!5.82e-16!83;UBERON:0009618!5.82e-16!83;UBERON:0007285!5.82e-16!83;UBERON:0002385!1.58e-15!63;UBERON:0001015!1.58e-15!63;UBERON:0000383!1.58e-15!63;UBERON:0004290!1.22e-14!70;UBERON:0001134!1.72e-14!61;UBERON:0002036!1.72e-14!61;UBERON:0003082!1.72e-14!61;UBERON:0002100!5.19e-14!216;UBERON:0003104!1.85e-13!238;UBERON:0009142!1.85e-13!238;UBERON:0000475!1.98e-13!365;UBERON:0000486!2.24e-13!82;UBERON:0001009!4.12e-13!113;UBERON:0000467!2.50e-12!625;UBERON:0000480!3.75e-12!626;UBERON:0004535!4.94e-12!110;UBERON:0004872!8.88e-12!84;UBERON:0003914!2.15e-11!118;UBERON:0002049!2.38e-10!79;UBERON:0007798!2.38e-10!79;UBERON:0000490!1.64e-09!138;UBERON:0000477!2.56e-09!286;UBERON:0000119!2.78e-09!312;UBERON:0000926!4.55e-09!448;UBERON:0004120!4.55e-09!448;UBERON:0006603!4.55e-09!448;UBERON:0000483!5.01e-09!309;UBERON:0007100!7.27e-09!27;UBERON:0000922!1.58e-08!612;UBERON:0001981!1.75e-08!60;UBERON:0007500!1.75e-08!60;UBERON:0004537!1.75e-08!60;UBERON:0006965!1.75e-08!60;UBERON:0000055!4.24e-08!69;UBERON:0002050!8.64e-08!605;UBERON:0005423!8.64e-08!605;UBERON:0001637!1.07e-07!42;UBERON:0003509!1.07e-07!42;UBERON:0004572!1.07e-07!42;UBERON:0007023!1.13e-07!115;UBERON:0003103!1.40e-07!69;UBERON:0000948!1.51e-07!24;UBERON:0005498!1.51e-07!24;UBERON:0004140!1.51e-07!24;UBERON:0009881!1.51e-07!24;UBERON:0004141!1.51e-07!24;UBERON:0003084!1.51e-07!24;UBERON:0007005!1.51e-07!24;UBERON:0004139!1.51e-07!24;UBERON:0004291!1.51e-07!24;UBERON:0000923!1.62e-07!604;UBERON:0005291!1.62e-07!604;UBERON:0006598!1.62e-07!604;UBERON:0002532!1.62e-07!604;UBERON:0004111!5.28e-07!241
}}
}}

Revision as of 14:40, 21 May 2012


Full id: C3750_smooth_bladder_Adipocyte_Mesenchymal_aorta_uterus_esophagus



Phase1 CAGE Peaks

Hg19::chr19:11650793..11650806,+p@chr19:11650793..11650806
+
Hg19::chr20:35169914..35169941,+p1@MYL9
Hg19::chr8:41986816..41986825,-p1@ENST00000520355


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0005859muscle myosin complex0.0105086541858001
GO:0016460myosin II complex0.0105086541858001
GO:0006937regulation of muscle contraction0.0105086541858001
GO:0008307structural constituent of muscle0.0105086541858001
GO:0044449contractile fiber part0.0106754582204953
GO:0043292contractile fiber0.0106754582204953
GO:0016459myosin complex0.0152983128963348
GO:0003012muscle system process0.0183484438164763
GO:0006936muscle contraction0.0183484438164763
GO:0051239regulation of multicellular organismal process0.0269312696017041
GO:0015629actin cytoskeleton0.0269312696017041



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
trunk mesenchyme2.09e-18143
multi-tissue structure3.08e-17347
multi-cellular organism4.39e-16659
somite5.82e-1683
paraxial mesoderm5.82e-1683
presomitic mesoderm5.82e-1683
presumptive segmental plate5.82e-1683
trunk paraxial mesoderm5.82e-1683
presumptive paraxial mesoderm5.82e-1683
muscle tissue1.58e-1563
musculature1.58e-1563
musculature of body1.58e-1563
dermomyotome1.22e-1470
skeletal muscle tissue1.72e-1461
striated muscle tissue1.72e-1461
myotome1.72e-1461
trunk5.19e-14216
mesenchyme1.85e-13238
entire embryonic mesenchyme1.85e-13238
organism subdivision1.98e-13365
multilaminar epithelium2.24e-1382
circulatory system4.12e-13113
anatomical system2.50e-12625
anatomical group3.75e-12626
cardiovascular system4.94e-12110
splanchnic layer of lateral plate mesoderm8.88e-1284
epithelial tube2.15e-11118
vasculature2.38e-1079
vascular system2.38e-1079
unilaminar epithelium1.64e-09138
anatomical cluster2.56e-09286
cell layer2.78e-09312
mesoderm4.55e-09448
mesoderm-derived structure4.55e-09448
presumptive mesoderm4.55e-09448
epithelium5.01e-09309
primary circulatory organ7.27e-0927
embryo1.58e-08612
blood vessel1.75e-0860
epithelial tube open at both ends1.75e-0860
blood vasculature1.75e-0860
vascular cord1.75e-0860
vessel4.24e-0869
embryonic structure8.64e-08605
developing anatomical structure8.64e-08605
artery1.07e-0742
arterial blood vessel1.07e-0742
arterial system1.07e-0742
adult organism1.13e-07115
compound organ1.40e-0769
heart1.51e-0724
primitive heart tube1.51e-0724
primary heart field1.51e-0724
anterior lateral plate mesoderm1.51e-0724
heart tube1.51e-0724
heart primordium1.51e-0724
cardiac mesoderm1.51e-0724
cardiogenic plate1.51e-0724
heart rudiment1.51e-0724
germ layer1.62e-07604
embryonic tissue1.62e-07604
presumptive structure1.62e-07604
epiblast (generic)1.62e-07604
anatomical conduit5.28e-07241


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.